Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...
Savant Capital LLC lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 14.4% in the 4th ...
Zacks.com on MSN4d
Should You Hold IDEXX Stock in Your Portfolio for Now?IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...
Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia ...
IDEXX Laboratories, Inc. IDXX has unveiled the IDEXX Cancer Dx ... development to positively boost market sentiment toward the stock. IDEXX currently has a market capitalization of $35.26 billion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback